Expression of cytokeratin by malignant meningiomas: Diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma

Modern Pathology

Volumn 17, Issue 9, 2004, Pages 1129-1133

  Liu, Yulin ^a,b   Sturgis, Charles D ^a   Bunker, Mark ^a   Saad, Reda S ^a   Tung, Ming ^a   Raab, Stephen S ^a   Silverman, Jan F ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Ber EP4; CEA; Cytokeratin; EMA; Immunohistochemistry; Malignant meningioma; Meningioma; Metastatic carcinoma

Indexed keywords

ANTIGEN B72.3; ANTIGEN BER EP4; CARCINOEMBRYONIC ANTIGEN; CD15 ANTIGEN; CELL MARKER; CYTOKERATIN; CYTOKERATIN AE1 AE3; CYTOKERATIN CAM 5.2; EPITHELIAL MEMBRANE ANTIGEN; PAN CYTOKERATIN; UNCLASSIFIED DRUG; VIMENTIN;

ANAMNESIS; ANTIGEN RETRIEVAL; ARTICLE; BENIGN TUMOR; CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MALIGNANT MENINGIOMA; METASTASIS; MORPHOLOGY; PRIORITY JOURNAL;

ANTIBODIES, NEOPLASM; ANTIGENS, CD15; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MENINGEAL NEOPLASMS; MENINGIOMA; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 4344627128     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800162     Document Type: Article

References (34)

1. Niedermayer I, Kolles H, Henn W, et al. Meningioma. Classification and grading. Patholology 1997;18: 353-358.
2. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;6:215-225.
3. Fabiani A, Trebini F, Favero M, et al. The significance of atypical mitoses in malignant meningiomas, Acta Neuropathol 1977;38:229-231.
4. New PF, Hesselink JR, O'Carroll CP, et al. Malignant meningiomas: CT and histologic criteria, including a new CT sign. AJNR Am J Neuroradiol 1982;3:267-276.
5. Mahmood A, Caccamo DV, Tomecek FJ, et al. Atypical and malignant meningiomas: a clinicopathological review. Neurosurg 1993;33:955-963.
6. Coke CC, Corn BW, Werner-Wasik M, et al. Atypical and malignant meningiomas: an outcome report of seventeen cases. J Neurooncol 1998;39:65-70.
7. Nagashima G, Asai J, Suzuki R, et al. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression. Brain Tumor Pathol 2001;1:1-5.
8. Miettinen M, Paetau A. Mapping of the keratin polypeptides in meningiomas of different types: an immunohistochemical analysis of 463 cases. Hum Pathol 2002;3:590-598.
9. Ng HK, Tse CC, Lo ST. Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers. Pathology 1987;19:253-257.
10. Ng HK, Wong AT. Expression of epithelial and extracellular matrix protein markers in meningiomas. Histopathology 1993;22:113-125.
11. Assi A, Declich P, Iacobellis M, et al. Secretory meningioma, a rare meningioma subtype with characteristic glandular differentation: an histological and immunohistochemical study of 9 cases. Adv Clin Path 1999;3:47-53.
12. Probst-Cousin S, Villagran-Lillo R, Lahl R, et al. Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases. Cancer 1997;79:2003-2015.
13. Colakoglu N, Demirtas E, Oktar, N, et al. Secretory meningiomas. J Neurooncol 2003;62:233-241.
14. Carlotti Jr CG, Neder L, Colli BO, et al. Clear cell meningioma of the fourth ventricle. Am J Surg Pathol 2003;27:131-135.
15. Hill JR, Kuriyama N, Kuriyama H, et al. Molecular genetics of brain tumors. Arch Neurol 1999;56: 439-441.
16. McLean CA, Jolley D, Cukier E, et al. Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator, Histopathology 1993;23: 349-353.
17. Yates AJ. An overview of principles for classifying brain tumors. Mol Chem Neuropathol 1992;17: 103-120.
18. Ang LC, Taylor AR, Bergin D, et al. An immunohistochemical study of papillary tumors in the central nervous system. Cancer 1990;65:2712-2719.
19. Jellinger K, Slowik F. Histological subtypes and prognostic problems in meningiomas. J Neurol 1975; 208:279-298.
20. Al-Sarraj S, King A, Martin AJ, et al. Ultrastructural examination is essential for diagnosis of papillary meningioma. Histopathology 2001;38:318-324.
21. Alguacil-Garcia A, Pettigrew NM, Sima AA. Secretory meningioma. A distinct subtype of meningioma. Am J Surg Pathol 1986;10:102-111.
22. Barnhart KF, Wojcieszyn J, Storts RW. Immunohistochemical staining patterns of canine meningiomas and correlation with published immunophenotypes. Vet Pathol 2002;39:311-321.
23. Giuffre G, Vitarelli E, Tuccari G, et al. Immunohistochemical study of Tn, sialosyl-Tn and T antigens in human meningiomas. Eur J Histochem 1998;42: 197-203.
24. Kasantikul V, Punyavoravut V, Maneesri S, et al. Mucin-producing malignant meningioma with papillary and glandular patterns. J Med Assoc Thai 1995;78: 635-640.
25. Radley MG, di Sant'Agnese PA, Eskin TA, et al. Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study - with review of the literature. Am J Clin Pathol 1989;92:266-272.
26. Terpe HJ, Kasper M, Martin H, et al. Detection of cytokeratin in cells of the arachnoid and in meningiomas. Zentralbl Allg Pathol 1988;134:259-264.
27. Slowinski J, Kaluza J, Sabat D, et al. Secretory meningioma of the brain. Report of two cases. Folia Neuropathol 1999;37:87-92.
28. Artlich A, Schmidt D. Immunohistochemical profile of meningiomas and their histological subtypes. Hum Pathol 1990;21:843-849.
29. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986;10:568-576.
30. Waldherr R, Schwechheimer K. Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carcinomas. Comparative study of the intermediate-sized filament distribution in renal cell carcinomas and normal human kidney. Virchows Arch A Pathol Anat Histopathol 1985; 408:15-27.
31. Santini D, Bazzocchi F, Paladini G, et al. Intermediate-sized filament proteins (keratin, vimentin, desmin) in metaplastic carcinomas, carcinosarcomas and stromal sarcomas of the breast. Int J Biol Markers 1987;2:83-86.
32. Cappello F, Aragona F, Serretta V, et al. Sarcomatoid carcinoma of urinary bladder: immunohistochemical study of an uncommon case. Urol Int 2002;69: 141-144.
33. DeLong W, Grignon DJ, Eberwein P, et al. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med 1993;117:636-640.
34. Stavale JN, Malheiros SM, Gabbai AA. Secretory meningioma. Report of two cases. Arq Neuropsiquiatr 1997;55:478-481.